The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
TRACON Pharmaceuticals, Inc(NASDAQ:TCON) 
TRACON Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for cancer and age-related macular degeneration and fibrotic diseases in the United States. Its lead clinical stage product include envafolimab (KN035), an inves...
Website: http://www.traconpharma.com
Founded: 2004
Full Time Employees: 19
Sector: Healthcare
Industry: Biotechnology
TRACON Pharmaceuticals Days Payable Outstanding ttm (DPO)
TRACON Pharmaceuticals Days Receivable Outstanding ttm (DSO)
TRACON Pharmaceuticals Op Cashflow Per Share ttm
TRACON Pharmaceuticals Free Cashflow Per Share ttm
TRACON Pharmaceuticals Cash Per Share ttm
TRACON Pharmaceuticals P/S ratio ttm
TRACON Pharmaceuticals (GAAP) P/E ratio ttm
TRACON Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.